Financings
Quantum licensee begins $5-million (U.S.) raise

QNTM · Price
Executive Summary
- Unbuzzd Wellness Inc., a licensee of Quantum Biopharma Ltd., has commenced a Regulation D 506(c) capital raise campaign to fund growth and establish a path to a potential initial public offering (IPO).
- The offering aims to raise up to $5.0 million (U.S.) from accredited investors, with investments accepted via traditional payments or cryptocurrency through ALT5 Pay.
- Quantum Biopharma states the offering will not dilute its shareholders due to an anti-dilution provision maintaining its 25% ownership stake in Unbuzzd Wellness until the company reaches a $1-billion valuation.
Key Details
- Capital Raise Structure: Regulation D 506(c) offering.
- Target Amount: Up to $5.0 million (U.S.).
- Purpose of Funds: Finance growth, direct-to-consumer expansion, distributor and retail expansion, and establish a path to a possible IPO.
- Investor Type: Accredited investors only.
- Payment Methods: Traditional payments or cryptocurrency payments via ALT5 Pay’s digital payments platform.
- Partners: MZ Digital (marketing) and Dealmaker (capital raising platform).
- Quantum Biopharma Ownership Terms:
- Maintains an anti-dilution provision ensuring 25% ownership in Unbuzzd Wellness until Unbuzzd reaches a $1-billion (U.S.) valuation.
- Current ownership stake: 20.11% (as of March 31, 2025).
- Upon Unbuzzd going public, Quantum Biopharma will access non-dilutive capital through its ownership.
- Royalty Agreement:
- Quantum Biopharma receives 7% of sales from Unbuzzd until total payments reach $250 million.
- After the $250 million threshold is met, the royalty drops to 3% in perpetuity.
- Quantum Biopharma retains 100% of rights to develop similar products or alternative formulations for pharmaceutical and medical uses.
Notable Quotes
- John Duffy, CEO of Unbuzzd Wellness: "This capital raise allows us to introduce investors to a new era in functional beverages aimed at supporting overall wellness after social occasions. Unbuzzd is a refreshing, science-backed beverage that helps people feel more refreshed and alert after drinking. This offering will help us raise the necessary capital to support direct-to-consumer, distributor and retail expansion plans."
- Gerry David, Board Co-Chair of Unbuzzd Wellness: "Together with our partners MZ Digital, a global leader in on-line marketing, and Dealmaker, a leading on-line platform for raising capital, we are excited to launch this offering to build our company and sales momentum, and position Unbuzzd for a future initial public offering."
More from Quantum Biopharma Ltd
Jun 26, 2026 · 08:30